In-vitro Antioxidant and Antilipidemic Activities of Xanthium...

10
1362 Current Trends in Biotechnology and Pharmacy Vol. 5 (3) 1362-1371 July 2011, ISSN 0973-8916 (Print), 2230-7303 (Online) Abstract In the present study Chloroform and alcohol extracts of Xanthium strumarium L. were evaluated for in vitro antioxidant and anti- lipidemic activity by various methods namely total reducing power, scavenging of free radicals such as 1,2-diphenyl-2-picrylhydrazyl (DPPH), super oxide, nitric oxide, and hydrogen peroxide. The percentage scavenging of various free radicals were compared with standard antioxidants such as ascorbic acid and Butylated hydroxyl toluene (BHT). The extracts were also evaluated for anti-lipidemic activity in Triton WR-1339 (iso-octyl polyoxyethylene phenol)- induced hyperlipidemia in Swiss albino rats by estimating serum triglyceride, very low density lipids (VLDL), cholesterol, low-density lipids (LDL), and high-density lipid (HDL) levels. Significant antioxidant activity was observed in all the methods, significant reduction (P < 0.01) in cholesterol at 6 and 24 h and (P < 0.05) at 48 h. There was significant reduction (P < 0.01) in triglyceride level at 6, 24, and 48 h. The VLDL level was also significantly (P < 0.05) reduced from 24 h and maximum reduction (P < 0.01) was seen at 48 h. There was significant increase (P < 0.01) in HDL at 6, 24, and 48 h. From the results; it is evident that alcohol and chloroform extracts of X. strumarium can effectively decrease plasma cholesterol, triglyceride, LDL, and VLDL and increase plasma HDL levels. Keywords: Anti-lipidemic, antioxidant, X. strumarium, triton Introduction Oxidation is one of the destructive processes, wherein it breaks down and damages various molecules. Oxygen via its transformation produces reactive oxygen species (ROS) such as super oxide, hydroxyl radicals, and hydrogen peroxide. They provoke uncontrolled reactions (1). Molecular oxygen is an essential component for all living organisms, but all aerobic species suffer from injury if exposed to concentration more than 21% (2). Free radicals attack and induce oxidative damage to various bio-molecules including proteins, lipids, lipoproteins, and DNA. The body possesses several defense systems comprising enzymes and radical scavengers. Some of them constitute the repair systems for bio-molecules that are damaged by the attack of free radicals (2, 3). An excessive and/or sustained increase in ROS production has been implicated in the pathogenesis of cancer, diabetes mellitus, In-vitro Antioxidant and Antilipidemic Activities of Xanthium strumarium L. N.B.Sridharamurthy 1 *, R. Yogananda 2 and Srinivas U. 3 1 Department of Pharmacology, Dayananda Sagar College of Pharmacy, Bangalore, India 2 Department of Pharmaceutics, SJM college of Pharmacy, Chitradurga, India 3 Department of Pharmacognosy, Srinivasa College of Pharmacy, Mangalore, India *For Correspondence - [email protected] In-vitro antioxidant and antilipidemic activities of Xanthium strumarium L.

Transcript of In-vitro Antioxidant and Antilipidemic Activities of Xanthium...

Page 1: In-vitro Antioxidant and Antilipidemic Activities of Xanthium …abap.co.in/sites/default/files/Paper-13_4.pdf · evaluated for in vitro antioxidant and anti-lipidemic activity by

1362Current Trends in Biotechnology and PharmacyVol. 5 (3) 1362-1371 July 2011, ISSN 0973-8916 (Print), 2230-7303 (Online)

AbstractIn the present study Chloroform and

alcohol extracts of Xanthium strumarium L. wereevaluated for in vitro antioxidant and anti-lipidemic activity by various methods namelytotal reducing power, scavenging of free radicalssuch as 1,2-diphenyl-2-picrylhydrazyl (DPPH),super oxide, nitric oxide, and hydrogen peroxide.The percentage scavenging of various freeradicals were compared with standardantioxidants such as ascorbic acid and Butylatedhydroxyl toluene (BHT). The extracts were alsoevaluated for anti-lipidemic activity in TritonWR-1339 (iso-octyl polyoxyethylene phenol)-induced hyperlipidemia in Swiss albino rats byestimating serum triglyceride, very low densitylipids (VLDL), cholesterol, low-density lipids(LDL), and high-density lipid (HDL) levels.Significant antioxidant activity was observed inall the methods, significant reduction (P < 0.01)in cholesterol at 6 and 24 h and (P < 0.05) at 48h. There was significant reduction (P < 0.01) intriglyceride level at 6, 24, and 48 h. The VLDLlevel was also significantly (P < 0.05) reducedfrom 24 h and maximum reduction (P < 0.01)was seen at 48 h. There was significant increase(P < 0.01) in HDL at 6, 24, and 48 h. From theresults; it is evident that alcohol and chloroformextracts of X. strumarium can effectively

decrease plasma cholesterol, triglyceride, LDL,and VLDL and increase plasma HDL levels.

Keywords: Anti-lipidemic, antioxidant, X.strumarium, triton

IntroductionOxidation is one of the destructive

processes, wherein it breaks down and damagesvarious molecules. Oxygen via its transformationproduces reactive oxygen species (ROS) such assuper oxide, hydroxyl radicals, and hydrogenperoxide. They provoke uncontrolled reactions(1). Molecular oxygen is an essential componentfor all living organisms, but all aerobic speciessuffer from injury if exposed to concentrationmore than 21% (2).

Free radicals attack and induce oxidativedamage to various bio-molecules includingproteins, lipids, lipoproteins, and DNA. The bodypossesses several defense systems comprisingenzymes and radical scavengers. Some of themconstitute the repair systems for bio-moleculesthat are damaged by the attack of free radicals(2, 3).

An excessive and/or sustained increase inROS production has been implicated in thepathogenesis of cancer, diabetes mellitus,

In-vitro Antioxidant and Antilipidemic Activities of Xanthiumstrumarium L.

N.B.Sridharamurthy1*, R. Yogananda2 and Srinivas U.3

1Department of Pharmacology, Dayananda Sagar College of Pharmacy, Bangalore, India2Department of Pharmaceutics, SJM college of Pharmacy, Chitradurga, India

3Department of Pharmacognosy, Srinivasa College of Pharmacy, Mangalore, India

*For Correspondence - [email protected]

In-vitro antioxidant and antilipidemic activities of Xanthium strumarium L.

Page 2: In-vitro Antioxidant and Antilipidemic Activities of Xanthium …abap.co.in/sites/default/files/Paper-13_4.pdf · evaluated for in vitro antioxidant and anti-lipidemic activity by

1363Current Trends in Biotechnology and PharmacyVol. 5 (3) 1362-1371 July 2011, ISSN 0973-8916 (Print), 2230-7303 (Online)

atherosclerosis, neurodegenerative diseases,rheumatoid arthritis, ischemia/reperfusion injury,obstructive sleep, apnea, and other diseases. Theprocess of aging may result, at least in part, fromradical-mediated oxidative damage was very wellexplained long ago (4).

Antioxidants are compounds that act asinhibitors of the oxidation process and are foundto inhibit oxidant chain reactions at smallconcentrations and thereby eliminate the threatof pathological processes (1). Phenoliccompounds present in medicinal plants have beenreported to possess powerful antioxidant activity(2). Flavonoids are a major class of phenoliccompounds present in medicinal plants and arefound to have a potential role in prevention ofvarious diseases through their antioxidantactivity (5).

X . strumarium (Asteraceae), is a shrubfound throughout India and warmer parts of theworld. This plant has been widely reported tohave several medicinal properties in traditionalform of medicine. The beneficial properties arediuretic, astringent, sedative, demulcent,diaphoretic, analgesic, sialagogue, styptic,sudorific, tonic, anodyne, antibacterial,antifungal, antispasmodic, bactericide, bitter,depressant, hemostat, laxative, refrigerant andanti- rheumatic. The leaves and roots are oftenused as anodyne, anti-rheumatic, appetizer,diaphoretic, diuretic, emollient, laxative andsedative, anti-malaria, bitter tonic, febrifuge andthe treatment of scrofulous tumors. A decoctionof the root has been used in the treatment of highfevers and oxytocic. Similarly, the seed’sdecoction is used in the treatment of bladdercomplaints and poultice of the powdered seedhas been applied to treat open sores. The fruitsare also reported for their use in the treatment oflesions, hypoglycemia, scrofula, fever, herpes,and cancer. X. strumarium is also used for many

domestic purposes. The fruits are boiled in waterand still drank as a tea in some parts of Asia.Cocklebur is also used in the manufacture of dye,repellent, and tannin. The dried plant repelsweeevils from stored wheat grain (6). There arealso very few reports available on thephytochemical and pharmacological activities ofXanthium strumarium L. and other speciesrelated to the genus Xanthium.

Earlier, workers on this plant haveextensively used the aerial parts of the plant,whereas the root being one of the important partsof the plant where in most of the activeconstituents are stored has not been subjectedfor systematic investigation. They are no reportsto show the use of roots of X. strumarium for thescreening of phytochemical analysis andpharmacological investigations. Hence, the rootserved as the core material for all theinvestigations carried out in the present study.Since polyphenolic compounds are present in theethanol and chloroform extracts of root of X.strumarium., it was thought that it would beworth while to evaluate the plant for antioxidantactivity. Lipids are one of the most susceptibletargets of free radicals. This oxidative destructionis known as lipid per oxidation and may inducemany pathological events. Apart fromantioxidant studies, the present study thereforealso involves evaluation of anti-lipidemicactivity.

Materials and MethodsPlant material and extraction: The root of X.strumarium were procured and authenticatedfrom Dr. Krishna, Professor and Taxonomist,Department of Bio-technology, KuvempuUniversity, Shimoga. The authenticated root wasdried in shade and powdered coarsely. Extractionwas done according to standard procedures usinganalytical grade solvents. Coarse powder of theroot was (1 kg) Soxhlet extracted with 90%

Sridharamurthy et al

Page 3: In-vitro Antioxidant and Antilipidemic Activities of Xanthium …abap.co.in/sites/default/files/Paper-13_4.pdf · evaluated for in vitro antioxidant and anti-lipidemic activity by

1364Current Trends in Biotechnology and PharmacyVol. 5 (3) 1362-1371 July 2011, ISSN 0973-8916 (Print), 2230-7303 (Online)

ethanol. The chloroform extract was preparedusing the same marc by the process ofmaceration. The extracts obtained wereconcentrated under reduced pressure to yield theethanol extract and chloroform extract of root(4.3 and 4.2%, respectively).

Preparation of test solution: The various extractsof X. strumarium root such as alcohol andchloroform were used for in vitro antioxidantstudies. Pilot studies were carried out for theethanol and chloroform extracts of root X.strumarium for in vitro antioxidant studies andthe concentrations at which the extracts gavegood antioxidant activity was selected.

Animals: Albino male Wister rats weighingbetween 150 and 200 g were procured fromregistered breeders. The animals were housedunder standard conditions of temperature (25±2°C) and relative humidity (30-70%) with a12:12 light-dark cycle. The animals were fed withstandard pellet diet and water ad libitum.Approval of the Institutional Animal EthicsCommittee (IAEC) of SJM College of Pharmacy,Chitradurga, was obtained.

Acute toxicity studies: Acute toxicity studies forchloroform and ethanol extracts of X. strumariumwere conducted as per OECD guidelines 423(7)using albino Wister rats. Each animal wasadministered the aqueous solution of the extractby oral route. The animals were observed for anychanges continuously for the first 2 h and up to24 h for mortality.

Antioxidant studies: The ability of the extractsto scavenge hydrogen peroxide, DPPH (1, 2-diphenyl-2-picrylhydrazyl) radical (8), nitricoxide (9,10), superoxide radical (4), and itsreducing power (8) was determined at differentconcentrations. Butylated hydroxy toluene(BHT) and ascorbic acid were used as standardsfor the various in vitro antioxidant studies. The

percentage scavenging of various radicals werecalculated using the following formula:

Where A 0 is absorbance of the free radical

alone and A 1 is absorbance of free radical in the

presence of extract/standard. All the experimentswere performed in triplicate.

Antilipidemic activity: The method of Tamasi etal (11). was used for evaluation of anti-lipidemicactivity. Albino Wister rats weighing between150 and 250 g were assigned to various groupsof six animals each. Animals were fasted for 16h prior to the experiment with water ad libitum.The X. strumarium ethanol and chloroformextract each at doses of 200 and 400 mg/kg bodyweight, Simvastatin at 4 mg/kg and Fenofibrateat 20 mg/kg, were administered p.o. Group Iserved as control. On the day of the experiment,the animals of the groups II-IV received therespective drugs by oral route. Simultaneously,all the animals received Triton WR-1339 at 100mg/kg body weight by intraperitoneal route. Thecontrol animals were given only Triton WR-1339at 100 mg/kg body weight. Serum cholesterol,triglyceride, and HDL were estimated at 6, 24,and 48 h using AGAPPE diagnostic kits. Bloodsamples were withdrawn by retro orbitalpuncture. Total cholesterol was estimated byCHOD-PAP methodology, Triglycerides byGPO-PAP methodology, and HDL by theprecipitation method using phosphotungstatemagnesium acetate reagent.

In-vitro antioxidant and antilipidemic activities of Xanthium strumarium L.

Page 4: In-vitro Antioxidant and Antilipidemic Activities of Xanthium …abap.co.in/sites/default/files/Paper-13_4.pdf · evaluated for in vitro antioxidant and anti-lipidemic activity by

1365Current Trends in Biotechnology and PharmacyVol. 5 (3) 1362-1371 July 2011, ISSN 0973-8916 (Print), 2230-7303 (Online)

Chemicals: The chemicals DPPH (1,2-diphenyl-2-picrylhydrazyl), N-(1-Naphthyl)thylenediamine dihydrochloride, Triton WR-1339, NADH, SNP, phenazine methosulphate,trichloro acetic acid, and potassium ferricyanidewere purchased from Sigma Chemicals, St Louis,MO, USA. All other chemicals and reagents usedwere of analytical grade. UV-1700 ShimadzuUV-Vis spectrophotometer was used for in vitroanti-oxidant studies.

Statistical analysis: All the values are presentedas mean SD. Data were statistically analyzedby one-way ANOVA followed by post hoc test;P values < 0.05 were considered as statisticallysignificant. Linear regression analysis was usedfor calculation of IC

50.

Acute toxicity studies: There was no mortalityand noticeable behavioral changes in all thegroups tested. The chloroform and ethanolextracts of root of X.strumarium were found tobe safe up to 2000 mg/kg body weight.

Results and DiscussionsHydrogen peroxide scavenging activity: At 125µg/ml concentration, the chloroform extract andethanol extract 100 µg/ml produced H

2O

2

scavenging activity comparable (P < 0.05) to that

of the standards BHT and ascorbic acid and werefound to have IC

50 (mean ± SD) of

8.89±1.10,9.15±1.21,10.18±1.50,9.23±0.91,respectively (Fig. 1; Table-1).

DPPH radical scavenging activity: Thechloroform and ethanol extract producedsignificant DPPH radical scavenging activity.The IC

50 (mean ± SD) of ascorbic acid, BHT

and other two extracts were found to be27.35±1.20, 26.01±0.93, 29.81±0.95, 24.85±2.49respectively (Table-1; Fig.1)

Fig. 1. Free radical activity of different extracts ofX. strumarium

Sridharamurthy et al

Table 1. Free radical scavenging activity of different activities of X. Strumanium

Page 5: In-vitro Antioxidant and Antilipidemic Activities of Xanthium …abap.co.in/sites/default/files/Paper-13_4.pdf · evaluated for in vitro antioxidant and anti-lipidemic activity by

1366Current Trends in Biotechnology and PharmacyVol. 5 (3) 1362-1371 July 2011, ISSN 0973-8916 (Print), 2230-7303 (Online)

Nitric oxide radical scavenging activity:Scavenging of nitric oxide by various extractswas found to be concentration dependent.Maximum inhibition of nitric oxide formationwas produced by alcoholic extract and had IC

50

of 495.30±3.09 as against 415.14± 5.98 for BHA(Fig. 1; Table-2).

Total reducing power: From 100 µg/ml,chloroform and ethanol extracts and standard-

ascorbic acid and BHA showed reductivecapabilities. At 500 µg/ ml, the reducing powerof standards and extracts showed the followingorder: BHA > ethanol extract > Ascorbic acid >chloroform. Reducing power of ethanol andchloroform extracts at 500µg/ml was comparable(P < 0.05) to that of ascorbic acid (Table-1).

Superoxide anion radical scavenging activity:Superoxide anion radical generation was

In-vitro antioxidant and antilipidemic activities of Xanthium strumarium L.

Table 2. Total reducing power, nitric oxide and super oxide scavenging activity of different concentrations of AA.BHA.XSCA,XSAE

Page 6: In-vitro Antioxidant and Antilipidemic Activities of Xanthium …abap.co.in/sites/default/files/Paper-13_4.pdf · evaluated for in vitro antioxidant and anti-lipidemic activity by

1367Current Trends in Biotechnology and PharmacyVol. 5 (3) 1362-1371 July 2011, ISSN 0973-8916 (Print), 2230-7303 (Online)

Fig. 2. Comparison of Total reducing power, Nitric Oxideand Super-oxide scavenging activity of 100mcg/ml of AA,BHA, Alcohol and Chloroform Extract of the root of X.

Fig. 3. Comparison of Total reducing power, Nitric Oxideand Super-oxide scavenging activity of 500mcg/ml of AA,BHA, Alcohol and Chloroform Extract of the root ofX. strumarium

Sridharamurthy et al

Fig. 4. Effects of Chloroform and ethanol extracts of rootof X.strumarium on total cholesterol and low density lipidslevels in triton-induced hyperlipidemic rats

6 hr

24 hr

48 hr

inhibited by BHA (standard) and extracts from100µg/ml. Both the extracts produced significantsuperoxide radical scavenging activity in aconcentration-dependent manner. Chloroformextract showed the lowest IC

50 value (418 ± 4.15)

which is better than BHA (415.14 ± 5.98).

Antihyperlipidemic activity: The non ionicdetergent, Triton WR-1339, has been widely usedto block the uptake of triacyl glycerol richlipoprotein from plasma by peripheral tissues inorder to produce acute hyperlipidemia in animalmodels which are often used for a number ofobjectives. The parenteral administration ofTriton induces hyperlipidemia in adult rats,where the blood cholesterol and triglycerideslevels were reached maximum in 20hrs, followedby a decline to normal values (12-14).Administration of Triton resulted in increase inserum levels of cholesterol, triglycerides, VLDL,and LDL. A significant reversal in serum levelsof cholesterol, triglycerides, VLDL, and LDLlevels was noticed in the animals treated with X.strumarium root extracts when compared withthe control group (Table-3). Simvastatin(standard) produced maximum cholesterol- andLDL-lowering effect at both 6 h and 24 h. ethanolextract 200 and Chloroform extract 400 produceda significant decrease in serum cholesterol and

Page 7: In-vitro Antioxidant and Antilipidemic Activities of Xanthium …abap.co.in/sites/default/files/Paper-13_4.pdf · evaluated for in vitro antioxidant and anti-lipidemic activity by

1368Current Trends in Biotechnology and PharmacyVol. 5 (3) 1362-1371 July 2011, ISSN 0973-8916 (Print), 2230-7303 (Online)

LDL levels, which was found to be significantlygreater than the effects of fenofibrate (at 6 h, 24h and 48 h) and simvastatin (at 48 h) (Table-3;Fig. 3). Maximum reduction of triglyceride andVLDL levels was produced by fenofibrate at 6h. At 24 h and 48 h, Chloroform and ethanolextracts of X. strumarium root producedsignificant triglyceride- and VLDL-loweringeffect which was comparable to that offenofibrate and significantly greater than that ofSimvastatin (Table-4, Fig-4). Simvastatin,fenofibrate, chloroform 400 and ethanol 200extracts 200 produced significant (P < 0.01)increases in serum HDL level at 6, 24, and 48 hwhen compared to control. At 6 h and 24 h

ethanol 200 and chloroform400 extractsproduced a significant (P < 0.01) increase in HDLlevel, which was significantly greater than thatof simvastatin and fenofibrate. At 48 h ethanol200 and chloroform 400, produced significant(P < 0.01) increase in HDL level, which wassignificantly greater than that of simvastatin andfenofibrate (Table-5; Fig-5).

The potentially reactive species of oxygenascribed as ROS such as superoxide radical,hydroxyl radical, and hydrogen peroxide arecontinuously generated inside the human bodyas a consequence of exposure to exogenouschemicals and/or a number of endogenous

In-vitro antioxidant and antilipidemic activities of Xanthium strumarium L.

Table 3. Effects of chloroform and ethanol extracts of root of X. strumarium, total cholesterol and low density lipids levels in triton-induced hyperlipidemic rats.

Table 4. Effects of chloroform and ethanol extracts of root of X. strumarium, on totaltriglyceride and low density lipids levels in triton-induced hyperlipidemic rats.

6 hr 24 hr 48 hr

6 hr 24 hr 48 hr

Page 8: In-vitro Antioxidant and Antilipidemic Activities of Xanthium …abap.co.in/sites/default/files/Paper-13_4.pdf · evaluated for in vitro antioxidant and anti-lipidemic activity by

1369Current Trends in Biotechnology and PharmacyVol. 5 (3) 1362-1371 July 2011, ISSN 0973-8916 (Print), 2230-7303 (Online)

ROS overproduction and/or inadequateantioxidant defense, there is upsurge of ROS andthis culminates in oxidative stress. It is quiteinteresting to note that plants have goodantioxidant ability and are safer than the syntheticantioxidants . The antioxidant activity can beattributed to various mechanisms like preventionof chain initiation, binding of transition metalion catalysts, decomposition of peroxides,reductive capacity, and radical scavengingactivity (4).

In the present study, five differentantioxidant methods for evaluation of antioxidantactivity have been used. Ethanol and chloroformextracts of X. Strumarium root producedsignificant antioxidant activity. This can beattributed to the flavonoids and other phyto-constituents present in the extracts, similar lipidlowering activity was also observed in the leafextracts of A.marmelos which may be attributedto the phyto-chemical constituents present in it,such as flavonoids, saponins and phenolicingredients as reported (15-16). Hyperlipidemiais one of the important risk factors involved inthe development of cardiovascular diseases (17).Increase HDL levels and reduction in LDL showsthe intensive conversion of LDL to HDL andclearance of circulating lipids. Total cholesterol/HDL-C ratio of >4.5 is associated with increasedcoronary heart disease (CHD) risk and the idealratio is <3.5(15, 16). Atherosclerosis andcongestive heart diseases are strongly associatedwith disorders of lipid metabolism and plasmalipoproteins. Triton WR-1339-treated rats areconsidered to be a useful acute hyperlipidemicmodel associated with inactive lipoprotein lipase(18). Triton WR-1339 acts as a surfactant to blockthe uptake of lipoprotein from the circulation byextra hepatic tissues resulting in an increase inthe level of circulatory lipoproteins (19).

Ethanol and chloroform extracts of X.Strumarium root produced significant cholesterol

Fig. 5. Effects of Chloroform and ethanol extracts of rootof X. strumarium on total triglyceride and very low den-sity lipids levels in triton- induced hyperlipidemic

Sridharamurthy et al

metabolic processes involving redox enzymesand bioenergetics electron transfer .Owing to the

Page 9: In-vitro Antioxidant and Antilipidemic Activities of Xanthium …abap.co.in/sites/default/files/Paper-13_4.pdf · evaluated for in vitro antioxidant and anti-lipidemic activity by

1370Current Trends in Biotechnology and PharmacyVol. 5 (3) 1362-1371 July 2011, ISSN 0973-8916 (Print), 2230-7303 (Online)

and LDL lowering effect at 6, 24, and 48 h. Thisindicates that X. strumarium not only reducesthe synthesis of cholesterol, but may also reduceits metabolism. The extracts were found to beenriched in flavonoids and phenolic compounds,it is reported that flavonoids are found to inhibitHMG-CoA reductase activity (18). It may beconcluded that the cholesterol-lowering effect ofX. Strumarium and root extracts may be due toinhibition of HMG-CoA reductase activity.Simvastatin being a specific HMG-CoA inhibitorproduces its hypocholesterolemic activity byreducing cholesterol synthesis.

Increase in triglyceride level was evidentin control animals due to inhibition of lipoproteinlipase (LPL) by Triton. Treatment with ethanoland chloroform extracts of X. strumariumresulted in reduction of triglyceride levels. It islikely that treatment with X. strumarium mighthave lowered the serum triglyceride level byactivating LPL. LPL is a prime enzyme relatedto triglyceride metabolism. Further VLDL levelswere reduced significantly at 24 and 48 h. Boththe extracts also showed protective action byincreasing serum HDL level. The increased HDLfacilitates the transport of triglyceride orcholesterol from serum to liver where it iscatabolised and excreted out of the body.

Significantly greater increase in HDL levels wasproduced by chloroform extract than ethanolextract.

ConclusionThe chloroform and ethanol extracts of X.

strumarium Linn. have shown significantantioxidant activity. From the preliminarystudies, it was found out that the chloroform andethanol extracts of X. strumarium have shownpromising anti-hyperlipidemic activity. Theantihyperlipedimic may be due their significantantioxidant activity.

References1. Nasik, S.R. (2003). Antioxidant and their

role in biological functions: An overview.Indian Drugs. 40:501-515.

2. Shetgiri, P.P. and D’Mello, P.M. (2003).Antioxidant activity of flavanoids-Acomparative a study. Indian Drugs.40:567-569.

3. Gopinathan, N., Srinivasan, K.K. andMathew, J.E. (2004). Free radicalscavenging properties of ethanol extract ofSaccharum spotaneum. Indian Drugs.41:633-635.

4. Gurpreet Kaur, Saqrwar, A.M., Zoobi, J.,Kaleem, J and Mohemmad, A. (2006).

In-vitro antioxidant and antilipidemic activities of Xanthium strumarium L.

Table 5. Effects of chloroform and ethanol extracts of root of X. strumarium on high density lipid levels in triton-induced hyperlipidemic rats

6 hr 24 hr 48 hr

Page 10: In-vitro Antioxidant and Antilipidemic Activities of Xanthium …abap.co.in/sites/default/files/Paper-13_4.pdf · evaluated for in vitro antioxidant and anti-lipidemic activity by

1371Current Trends in Biotechnology and PharmacyVol. 5 (3) 1362-1371 July 2011, ISSN 0973-8916 (Print), 2230-7303 (Online)

Evaluation of antioxidant activity ofCassiaa siamea flower. J,Ethanopharmacol. 108:340-348.

5. Droge, W. (2002). Free radicals in thephysiological control of cell function.Physiol Rev. 82: 47-95.

6. Agharkar, S.P. (1991). Medicinal plants ofBombay presidency. Scientific Publishers,Jodhpur. (India). 230.

7. Available from:www.oecd.org.chs.

8. llhami, G.A., Haci, A.A and Mehmet, C.(2005). Determination of in vitroantioxidant and 15 radical scavengingactivities of propofol. Chem Pharma Bull.53:281-285.

9. Yaowared, S., Yukihisa, M., Michihisa, T.,Opa, V., Kinzo, M., Hiroshi, W. ( 2004).Evaluation of the nitric oxide radicalscavenging activity of ManganeseComplex of curcumin and its derivative.Biol Pharma Bull. 271:70-3.

10. Kumar, R.S., Sivakumar,T., Sunderm, R.S.,Gupta, M., Mazumdar, U.K., Gomthi, P.(2005). Antioxidant and antimicrobialactivities of Bauhinia racemosa L.stembark. Braz J Med Biol Res. 38:1015-24.

11. Tamasi, G., Borsy, J. and Patthy, A. (1968).Effect of 3-carboxyl-5-methylpyrazole(CMP) on serum and liver enzymes.Biochem Pharmacol. 7:1789-794.

12. Sarvanakumar, A., Vanitha, S., Ganesh,M., Jayaprakash, J., Ramaswamy, N.M.(2010). Hypolipidemic activity of Sesbaniagrandiflora in Triton WR-1339 inducedhyperlipidemic rats. International Journalof Phytomedicine. 2:52-58.

13. Arunkumar Dubey, Ahalya devi, GopalanKutty and Ravi Pathiyil Kutty. (2005).Hypolipidemic activity of GinkobilobaExtract, EGb 761 in hypercholesrolemiaWiistar Rats. Indian Journal ofPharmaceutical Technology. 41:9-12.

14. Firdous S.M., Banerjee Subhasis andKoneri R. (2010). Antihyperlipidemicactivity of Momordica dioica Roxb. Int. J.Drug Dev & Res.2 (1): 108-112.

15. Pengelly Andrew (2004). Triterpenoids andsaponins. The constituents of medicinalplants (CABI publishing, USA), 74.

16. Regisusan, D.M.C., Devi, K. S. and AugustiK. T. (1998). Antioxidant effect of twoflavonoids from the bark of Ficusbengalensis Linn in hyperlipdaemic rats.Indian J Exp Biol. 36: 902.

17. Castelli, W. P., Garrison, R. J., Wilson, P.W. F., Abbott, R.D., Kaloudian, S. andKannel, W.B. (1986). Incidence of coronaryheart disease and lipoprotein cholesterollevels-The Firmingham Study. JAMA,256: 2835.

18. Xie, W., Wang, W., Su, H., Xing, D., Cal,G and Du, L. (2007). Hypolipidemicmechanisms of Ananas comosus L Leavesin mice: Different from fibrates but similarto statins. J Pharmacol Sci. 103:267-74.

19. Umesh, K.P., Saraf S. and Dixit, V.K.(2004). Hypolipidemic activity of seedsCassia tora. J Ethanopharmacol. 90:249-52.

Sridharamurthy et al